Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Clinical Pharmacology in Drug Development|January 19, 2026
LP-001, a Novel Long-Acting EPO-Fc Fusion Protein: A Phase I Dose-Escalation Study of Pharmacokinetics, Safety, and Tolerability in Healthy Chinese SubjectsJie Yang, Jiaxiang Ding, Yuanyuan Xu, et al.
Oncology Reports|April 17, 2018
Chloroquine inhibits cell growth in human A549 lung cancer cells by blocking autophagy and inducing mitochondrial‑mediated apoptosisLikun Liu, Cuicui Han, Haitao Yu, et al.
Colloids and Surfaces. B, Biointerfaces|January 9, 2023
Novel PLCL nanofibrous/keratin hydrogel bilayer wound dressing for skin wound repairMiaomiao Zhang, Shixin Xu, Chen Du, et al.
Horticulture Research|April 30, 2025
CYP98A monooxygenases: a key enzyme family in plant phenolic compound biosynthesisZheng Zhou, Yonghao Duan, Yajing Li, et al.
Frontiers in Bioscience (Landmark Edition)|July 7, 2026
Transcriptomic Insights Into Brassinolide-Mediated Control of Bioactive Compound Biosynthesis in Salvia miltiorrhiza BungeWenjiao Ma, Qing Li, Wenhui Wu, et al.
Molecules (Basel, Switzerland)|September 28, 2024
Discovery and Optimization of Ergosterol Peroxide Derivatives as Novel Glutaminase 1 Inhibitors for the Treatment of Triple-Negative Breast CancerRan Luo, Haoyi Zhao, Siqi Deng, et al.
Bioorganic Chemistry|October 3, 2024
Design and synthesis of novel mitochondria-targeted ergosterol peroxide derivatives as potential anti-cancer agentsLu Wang, Shuang Tian, Siqi Deng, et al.
Plant Communications|July 16, 2026
SmNAC36 promotes the biosynthesis of bioactive compounds and drought tolerance in Salvia miltiorrhizaZheng Zhou, Cuicui Han, Yun Wang, et al.
BMC Cancer|August 27, 2024
Acetylation of PGK1 at lysine 323 promotes glycolysis, cell proliferation, and metastasis in luminal A breast cancer cellsXiuli Gao, Ting Pan, Yu Gao, et al.
Bioorganic & Medicinal Chemistry|November 22, 2024
Thiazolidinedione-based structure modification of ergosterol peroxide provides thiazolidinedione-conjugated derivatives as potent agents against breast cancer cells through a PI3K/AKT/mTOR pathwaySiqi Deng, Lu Wang, Shuang Tian, et al.
Pageof 3